Sedation Intensity in the First 48 Hours of Mechanical Ventilation and 180-Day Mortality: A Multinational Prospective Longitudinal Cohort Study
Yahya Shehabi, Rinaldo Bellomo, Suhaini Kadiman, Lian Kah Ti, Belinda Howe, Michael C Reade, Tien Meng Khoo, Anita Alias, Yu-Lin Wong, Amartya Mukhopadhyay, Colin McArthur, Ian Seppelt, Steven A Webb, Maja Green, Michael J Bailey
Critical Care Medicine | LIPPINCOTT WILLIAMS & WILKINS | Published : 2018
The parent SPICE studies were supported by an unrestricted research grant from Pfizer (Hospira, Lake forest, IL), Grant-in-Aide Program.Dr. Shehabi declares unrestricted research and educational grant support from Pfizer (Hospira, Lake Forest, IL), Orion Pharma - Helsinki Finland in support of the Sedation Practice in Intensive Care Evaluation Program. Dr. Reade declares unrestricted research and educational grant support from Pfizer (Hospira, Melbourne, VIC) Australia. Dr. McArthur disclosed project grant funding from the Health Research Council of New Zealand for a prospective, randomized clinical trial of intensive care sedation. The remaining authors have disclosed that they do not have any potential conflicts of interest.